Ramifications of HLA class I polymorphism and population genetics for vaccine development.
about
Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligandsComprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted SpecificitiesDirect ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutininPredicting population coverage of T-cell epitope-based diagnostics and vaccines.Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian populationHLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivityImmunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.Risk factors for febrile respiratory illness and mono-viral infections in a semi-closed military environment: a case-control study.Variation in vaccine response in normal populations.Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines.Elicitation from virus-naive individuals of cytotoxic T lymphocytes directed against conserved HIV-1 epitopes.Human leukocyte antigen alleles, genotypes and haplotypes frequencies in renal transplant donors and recipients from West Central India.MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles.Derivation of HLA types from shotgun sequence datasets.
P2860
Q24673636-242CB556-7C18-4AAB-A79C-02003BAAE01CQ24812058-22F3AF23-B07C-4299-BDD0-3C95B573A86AQ27472881-E4FCDF3E-1C8D-40F4-AD2D-6D07A28B0BB6Q30361736-F7DC8733-11FC-47C6-8ACB-ECF07CC375A8Q33236900-5B23FCF0-585E-48E7-B36D-3DED62D02D82Q33712097-DA77CDA5-90F7-4AD8-A1E2-88D789FCB68DQ34999573-111B8800-AA1E-44E2-AD4C-964BF9E39D24Q35077438-24E8117A-A7C7-491E-87DF-100ABAAC84CCQ35712381-4A89BBED-090D-4CEC-8B5D-16C35D349C30Q35785237-91A31460-46A3-4C34-AC4D-9C4D3CD08281Q36383797-41173232-946F-4930-AF00-26E2CCB8C3DCQ42024536-1D4744FB-333F-4D90-8A6C-DF21BEBA66C5Q42578971-AA1AC972-91F3-4E7E-BE1C-0066C361D38AQ42729706-95336077-E22E-409C-B793-D4999D1E8D4EQ43241315-F2BF4D75-CBB2-4AF0-BE88-52D5B765FD3E
P2860
Ramifications of HLA class I polymorphism and population genetics for vaccine development.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Ramifications of HLA class I p ...... etics for vaccine development.
@en
Ramifications of HLA class I p ...... etics for vaccine development.
@nl
type
label
Ramifications of HLA class I p ...... etics for vaccine development.
@en
Ramifications of HLA class I p ...... etics for vaccine development.
@nl
prefLabel
Ramifications of HLA class I p ...... etics for vaccine development.
@en
Ramifications of HLA class I p ...... etics for vaccine development.
@nl
P2093
P2860
P1433
P1476
Ramifications of HLA class I p ...... etics for vaccine development.
@en
P2093
P2860
P304
P356
10.1002/1098-2272(200101)20:1<87::AID-GEPI8>3.0.CO;2-R
P577
2001-01-01T00:00:00Z